Prelude Therapeutics Inc - Common Stock, par value $0.0001 per share (PRLD)

Q4 2023 13F Holders as of 12/31/2023

Type / Class
Equity / Common Stock, par value $0.0001 per share
Number of holders
55
Total Shares
34.7M
Shares change
-1.94M
Total reported value, excl. options
$148M
Value change
-$6.55M
Put/Call ratio
1.43
Number of buys
33
Number of sells
-22
Price
$4.27
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.